SCHEMBL6967541

SCHEMBL6967541

CCOC(=O)CC1CCc2[nH]cnc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
JAK3 P52333 1/20 0.39
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
MIF P14174 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
ADRA1A P35348 2/20 0.33
ADRA1D P25100 1/20 0.33
HTR3A P46098 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6969193 0.88 TDP1 (0.38) ALDH1A1TDP1KDM4EHSD17B10TP53
Hydrochloric Acid SCHEMBL6969189 0.86 TDP1 (0.38) ALDH1A1TDP1KDM4EHSD17B10TP53
SCHEMBL6849697 0.81 ALDH1A1 (0.44) ALDH1A1TDP1KDM4EHSD17B10GAA
SCHEMBL6849832 0.80 ADRA1A (0.35) ALDH1A1TDP1ADRA1AADRA1DHTR3A
Hydrochloric Acid SCHEMBL6846931 0.80 ALDH1A1 (0.43) ALDH1A1TDP1KDM4EHSD17B10GAA
SCHEMBL8482514 0.79 PDK1 (0.46) ALDH1A1KDM4EHSD17B10TSHRGAA
SCHEMBL6967215 0.77 KMT2A (0.43) ALDH1A1TDP1KDM4EHSD17B10TP53
Hydrochloric Acid SCHEMBL6961742 0.72 ADRA1A (0.37) HSD17B10ADRA1AHTR3AADRA2AADRA2B
SCHEMBL27313851 0.71 KMT2A (0.40) JAK2JAK1TYK2JAK3ALDH1A1
SCHEMBL12578889 0.71 ADRA1A (0.40) ADRA1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610721-B2 Imidazo heterocyclic compounds NOVO NORDISK A/S (DK) 2003-08-26 US disclosed
EP-1268483-A1 CONDENSED IMIDAZOLES AS HISTAMINE H3 RECEPTOR LIGANDS NOVO NORDISK A/S (DK) 2003-01-02 EP disclosed
US-20010049385-A1 Imidazo heterocyclic compounds HIGH POINT PHARMACEUTICALS, LLC 2001-12-06 US disclosed
WO-2001068651-A1 CONDENSED IMIDAZOLES AS HISTAMINE H3 RECEPTOR LIGANDS NOVO NORDISK A/S (DK) 2001-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049385-A1 Imidazo heterocyclic compounds HRH4, HRH3, HRH2 JAK2 365/4885JAK1 935/4885TYK2 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.